One possible explanation is that, under normal conditions, p53 signaling dominant in PiHL regulation in p53 wildtype CRC cells, while in p53 mutant cells, HMGA2 plays a superior role in PiHL signaling. This evidence concerns the gene TP53 and colorectal carcinoma.